1.Comparative study on effect of acupuncture and lidocaine block for lumbar myofascial pain syndrome.
Gui-Mei JIANG ; Mou-De LIN ; Lu-Ying WANG
Chinese Acupuncture & Moxibustion 2013;33(3):223-226
OBJECTIVETo observe the clinical efficacy of acupuncture at Jiaji (EX-B 2) points mainly for lumbar myofascial pain syndrome (MPS).
METHODSSixty-six cases of MPS were randomized into an acupuncture group and a lidocaine group, 33 cases in each group. The acupuncture group was treated with acupuncture at Jiaji (EX-B 2) points combined with needling local myofascial trigger points (MTrP), and the lidocaine group was treated with local block at trigger points with lidocaine injection. The treatment was given once every 2 days. After three and five times of the treatment, the simplified McGill scale, Oswestry disability index (ODI) and pressure-pain threshold were assessed to compare the therapeutic effects between the two groups.
RESULTSAfter treatment, the scores of simplified McGill and ODI of two groups were obviously reduced while the score of pressure-pain threshold was obviously increased (all P < 0.01). After three and five times of the treatment, there were no significant differences in above scores between the two groups (all P > 0.05).
CONCLUSIONAcupuncture at Jiaji (EX-B 2) points combined with needling MTrP is an effective and safe therapy for lumbar MPS, the therapeutic effect is equal to lidocaine block.
Acupuncture Points ; Acupuncture Therapy ; Adult ; Female ; Humans ; Injections ; Lidocaine ; administration & dosage ; Male ; Middle Aged ; Myofascial Pain Syndromes ; drug therapy ; physiopathology ; therapy ; Treatment Outcome ; Trigger Points ; physiopathology ; Young Adult
2.Intervention effect of Qufeng Gutong Cataplasm on myofascial pain syndrome in rats and its mechanism.
Xue-Ying TAO ; Chao WANG ; Feng-Yu HUANG ; Xin-Zhuo ZHANG ; Chun-Fang LIU ; Xiao-Hui SU ; Na LIN
China Journal of Chinese Materia Medica 2023;48(14):3855-3864
This paper aims to investigate the intervention effect of Qufeng Gutong Cataplasm(QFGT) on myofascial pain syndrome(MPS) in rats and to preliminarily explain its mechanism from the perspective of improving muscle inflammation and pain. Male SD rats were divided into 6 groups, namely normal group, model group, positive control drug(Huoxue Zhitong Ointment, HXZT) group, and low, medium, and high-dose QFGT groups(75, 150, and 300 mg·d~(-1)). The rat model of MPS was established by striking combined with centrifugation for 8 weeks, during which QFGT and HXZT were used for corresponding intervention. Standard VonFrey fiber was used to evaluate the mechanical pain threshold, and acetone was used to detect the cold pain threshold. The electrophysiological activity of muscle at trigger point was detected, and the electromuscular analysis of trigger point was performed. CatWalk gait analyzer was used to detect pain-induced gait adaptation changes. The hematoxylin-eosin(HE) staining was used to observe the pathological changes in muscle and skin tissues at the trigger point of rats. Immunohistochemistry was used to detect the expression of capsaicin receptor transient receptor potential vanilloid 1(TRPV1) in muscle tissues and interleukin(IL)-33 in skin tissues at the trigger point. The protein expression levels of TRPV1, protein kinase B(Akt), phosphorylated protein kinase B(p-Akt), IL-1β, and tumor necrosis factor-α(TNF-α) in muscle tissues at the trigger point were detected by Western blot. The results showed that as compared with the model group, the mechanical pain threshold and cold pain threshold of rats in other groups were increased after treatment with QFGT. The spontaneous electromyography(EMG) activity was observed in the model group, but QFGT alleviated the EMG activity in a dose-dependent manner. Gait analysis showed that standing duration, average intensity, swing speed, maximum contact point, maximum contact area, paw print length, paw print width, and paw print area were significantly improved in all QFGT groups. Pathological results showed that the disorder of muscle arrangement at the trigger point was decreased, muscle fiber adhesion and atrophy were reduced, and inflammatory cell infiltration was alleviated after treatment with QFGT. In addition, QFGT and HXZT both inhibited the protein expression of TRPV1, PI3K, Akt, p-Akt, IL-1β, and TNF-α in the muscle tissues of rats with MPS. However, there was no significant difference in the pathological structure and expression of IL-33 in the treated skin as compared with the normal group. The related results have proved that QFGT can inhibit the release of inflammatory factors by inhibiting the TRPV1/PI3K/Akt signaling pathway in the muscle trigger point of rats with MPS and finally attenuate the atrophy and adhesion of local muscles and inflammatory infiltration, thereby relieving the muscle pain of rats with MPS, and local administration has no skin irritation.
Rats
;
Male
;
Animals
;
Proto-Oncogene Proteins c-akt
;
Rats, Sprague-Dawley
;
Tumor Necrosis Factor-alpha
;
Phosphatidylinositol 3-Kinases
;
Myofascial Pain Syndromes/drug therapy*
;
Pain
3.Application of Ultrasound-Guided Trigger Point Injection for Myofascial Trigger Points in the Subscapularis and Pectoralis Muscles to Post-Mastectomy Patients: A Pilot Study.
Hyuk Jai SHIN ; Ji Cheol SHIN ; Wan Sung KIM ; Won Hyuk CHANG ; Sang Chul LEE
Yonsei Medical Journal 2014;55(3):792-799
PURPOSE: To investigate the therapeutic effectiveness of ultrasound (US)-guided trigger point injection for myofascial trigger points (MTrPs) in the internal rotator muscles of the shoulder in post-mastectomy patients. MATERIALS AND METHODS: This pilot study was a non-controlled, prospective, clinical trial. Nineteen post-mastectomy patients with a diagnosis of at least one active MTrP in the subscapularis and/or pectoralis muscles were included. We performed trigger point injections into the subscapularis muscle deep behind the scapula as well as the pectoralis muscle for diagnostic and therapeutic purpose by the newly developed US-guided method. RESULTS: Visual analogue scale and range of motion of the shoulder for external rotation and of abduction showed significant improvement immediately after the first injection and 3 months after the last injection compared with baseline (p<0.05 for both). Duration from onset to surgery and duration of myofascial pain syndrome in the good responder group were significantly shorter than in the bad responder group (p<0.05). Patients did not report any complications related to the procedure or serious adverse events attributable to the treatment. CONCLUSION: In post-mastectomy patients with shoulder pain, US-guided trigger point injections of the subscapularis and/or pectoralis muscles are effective for both diagnosis and treatment when the cause of shoulder pain is suspected to originate from active MTrPs in these muscles, particularly, the subscapularis.
Adult
;
Aged
;
Anesthetics, Local/administration & dosage/therapeutic use
;
Female
;
Humans
;
Injections, Intramuscular/methods
;
Lidocaine/administration & dosage/therapeutic use
;
Mastectomy
;
Middle Aged
;
Muscle, Skeletal/drug effects/ultrasonography
;
Myofascial Pain Syndromes/drug therapy
;
Pectoralis Muscles/drug effects/*ultrasonography
;
Trigger Points/*ultrasonography
4.Myositis Ossificans of the Elbow after a Trigger Point Injection.
Sang Jin SHIN ; Sung Shik KANG
Clinics in Orthopedic Surgery 2011;3(1):81-85
Trigger point injection is a simple procedure that is widely performed for relieving pain. Even though there are several complications of trigger point injection, myositis ossificans has not been documented as one of its complications. We treated a patient who suffered from painful limitation of elbow motion and this was caused by myositis ossificans between the insertions of brachialis and supinator muscles after a trigger point injection containing lidocaine mixed with saline, and we also review the relevant medical literature.
Adult
;
Elbow/surgery
;
Humans
;
Injections, Intralesional/*adverse effects
;
Lidocaine/*adverse effects/therapeutic use
;
Magnetic Resonance Imaging
;
Male
;
Myofascial Pain Syndromes/drug therapy
;
Myositis Ossificans/diagnosis/*etiology/radiotherapy/surgery
;
Range of Motion, Articular